Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Clinical trial NCT01679990 · COMPLETED

Trial details

NCT number: NCT01679990
Sponsor: Pluristem Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Intermittent Claudication Peripheral Artery Disease

Start date: 2012-11-05
Primary completion: 2018-03-29
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.